Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate

被引：0
作者：
Sang-Won Lee
Hee-Jin Park
Beom Kyung Kim
Kwang-Hyub Han
Soo-Kon Lee
Seung Up Kim
Yong-Beom Park
机构：
[1] Yonsei University College of Medicine,Department of Internal Medicine
[2] Yonsei University College of Medicine,Institute for Immunology and Immunological Diseases
[3] Yonsei University College of Medicine,Department of Medical Sciences
[4] Yonsei University College of Medicine,Institute of Gastroenterology
[5] Yonsei University College of Medicine,Liver Cirrhosis Clinical Research Center
来源：
Arthritis Research & Therapy | / 14卷
关键词：
Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Chronic Liver Disease; Liver Fibrosis; Cumulative Dose;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study)
    Martin Feuchtenberger
    Lisa Kraus
    Axel Nigg
    Hendrik Schulze-Koops
    Arne Schäfer
    Rheumatology International, 2021, 41 : 1079 - 1087
  • [32] Initial methotrexate dosage is not associated with an increased risk of liver toxicity in patients with rheumatoid arthritis
    Se Rim Choi
    Jun Won Park
    Eun Bong Lee
    Jin Kyun Park
    Clinical Rheumatology, 2021, 40 : 4493 - 4500
  • [33] Initial methotrexate dosage is not associated with an increased risk of liver toxicity in patients with rheumatoid arthritis
    Choi, Se Rim
    Park, Jun Won
    Lee, Eun Bong
    Park, Jin Kyun
    CLINICAL RHEUMATOLOGY, 2021, 40 (11) : 4493 - 4500
  • [34] Assessment of liver fibrosis in patients with rheumatoid arthritis treated with methotrexate: Utility of fibroscan and biochemical markers in routine clinical practice
    de Diego-Sola, Andrea
    Eguzkiza, Agustin Castiella
    Dominguez, Luis Maria Lopez
    Barallobre, Iratxe Urreta
    Iturri, Maria Jose Sanchez
    Otano, Joaquin Maria Belzunegui
    Methotrexate Fibrosis Grp
    REUMATOLOGIA CLINICA, 2023, 19 (08): : 412 - 416
  • [35] Assessment of liver fibrosis by transient elastography and procollagen III amino terminal propeptide in rheumatoid arthritis patients treated with methotrexate
    Ghaleb, Rasha M.
    Mohamed, Doaa M.
    Zaki, Zaki M.
    Ameen, Nadia F. El
    Hamed, Ahmed
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2024, 55 (01)
  • [36] Risk factors of severe infections in patients with rheumatoid arthritis treated with leflunomide
    Yoo, Han-Gyul
    Yu, Hea Min
    Jun, Jeon Byung
    Jeon, Hyun-Soon
    Yoo, Wan-Hee
    MODERN RHEUMATOLOGY, 2013, 23 (04) : 709 - 715
  • [37] Infectious risk of add-on leflunomide or tacrolimus versus TNF inhibitors among patients with rheumatoid arthritis receiving background methotrexate: A population-based cohort study
    Shin, Anna
    Lee, Joo Ho
    Ha, You-Jung
    Lee, Yun Jong
    Lee, Eun Bong
    Kang, Eun Ha
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2022, 55
  • [38] INCIDENCE, PREVALENCE AND POSSIBLE RISK-FACTORS FOR PNEUMONITIS IN PATIENTS WITH RHEUMATOID-ARTHRITIS RECEIVING METHOTREXATE
    CARROLL, GJ
    THOMAS, R
    PHATOUROS, CC
    ATCHISON, MH
    LESLIE, AL
    COOK, NJ
    DSOUZA, I
    JOURNAL OF RHEUMATOLOGY, 1994, 21 (01) : 51 - 54
  • [39] Evaluation of efficacy of combination of methotrexate and hydroxychloroquine with leflunomide in active rheumatoid arthritis
    Shashikumar, N. S.
    Shivamurthy, M. C.
    Chandrashekara, S.
    INDIAN JOURNAL OF PHARMACOLOGY, 2010, 42 (06) : 358 - 361
  • [40] Treating rheumatoid arthritis with leflunomide monotherapy versus combination therapy with methotrexate
    Guadagnin, Daniel Ampessan
    Mazzali, Leonardo Vinicius
    Skare, Thelma Larocca
    Kahlow, Barbara Stadler
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2021, 8 (01) : 12 - 15
12345